Trial Profile
A Multicenter, Randomized, Placebo And Active-Controlled Study Of The Effect Of CJ-023,423 On The Incidence Gastroduodenal Endoscopic Ulcers In Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Feb 2010
Price :
$35
*
At a glance
- Drugs Grapiprant (Primary) ; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions
- Sponsors Pfizer
- 12 Dec 2006 Status change
- 22 Nov 2006 New trial record.